MorphoSys (NASDAQ:MOR) Receives New Coverage from Analysts at Wells Fargo & Company

Wells Fargo & Company began coverage on shares of MorphoSys (NASDAQ:MOR – Get Rating) in a research note released on Friday morning, The Fly reports. The firm issued an overweight rating and a $17.00 target price on the stock. A number of other equities analysts have also commented on the company. UBS Group assumed coverage […]

Related Keywords

,Jpmorgan Chase Co ,Wells Fargo Company ,Citadel Advisors ,Susquehanna International Group ,Sigma Securities ,Virtu Financial ,Wells Fargo ,Get Rating ,International Group ,Two Sigma Securities ,Morphosys Daily ,Morphosys ,Nasdaq Mor ,Humor ,Medical ,Initiated Coverage ,